Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-19

Clinical Trial Update: Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pharmacokinetics of risperidone and 9-hydroxy risperidone from a polyurethane implant in stabilized schizophrenic patients; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Braeburn Pharmaceuticals | Conditions: Schizophrenia, Schizo-affective Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-02-19